The DOI matches its Crossref record.
Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most (eight) showed positive results, with significant differences vs placebo in NIH‐CPSI total, urinary symptom, pain, and/or QoL scores 54, 55, 56, 57, 59, 60, or in scores using other validated symptom scoring tools 58, 61.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [60]
In the citing paper
“In all, 10 placebo‐controlled RCTs (n = 58–272) were identified that evaluated α‐adrenergic antagonists (tamsulosin 53, 54, 55, alfuzosin 56, 57, doxazosin 58, 59, terazosin 60, 61 and silodosin 62) in CBP and CP/CPPS.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 15
- Nickel, 2001, Prevalence of prostatitis-like symptoms in a population-based study using the National Institutes of Health Chronic Prostatitis Symptom Index, J Urol, 165, 842, 10.1016/S0022-5347(05)66541-X · DOI · Paper page
- Cheah, 2003, Chronic prostatitis, Urology, 61, 60, 10.1016/S0090-4295(02)02081-2 · DOI
- Wenninger, 1996, Sickness impact of chronic nonbacterial prostatitis and its correlates, J Urol, 155, 965, 10.1016/S0022-5347(01)66359-6 · DOI · Paper page
- Calhoun, 2004, The economic impact of chronic prostatitis, Arch Intern Med, 164, 1231, 10.1001/archinte.164.11.1231 · DOI
- Schaeffer, 2002, Overview summary statement, Urology, 60, 1, 10.1016/S0090-4295(02)01979-9 · doi:10.1016/s0090-4295(02)01979-9
- Nickel, 1999, Research guidelines for chronic prostatitis, Urology, 54, 229, 10.1016/S0090-4295(99)00205-8 · DOI · Paper page
- Alexander, 2004, A randomized trial of ciprofloxacin and tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome, J Urol, 171, 61, 10.1016/S0022-5347(18)37494-9 · doi:10.1016/s0022-5347(18)37494-9
- Cheah, 2003, Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome, J Urol, 169, 592, 10.1016/S0022-5347(05)63960-2 · doi:10.1016/s0022-5347(05)63960-2
- Krieger, 1999, NIH consensus definition and classification of prostatitis, JAMA, 282, 236, 10.1001/jama.282.3.236 · DOI · Paper page
- Litwin, 1999, The National Institutes of Health Chronic Prostatitis Symptom Index, J Urol, 162, 369, 10.1016/S0022-5347(05)68562-X · DOI · Paper page
- Meares, 1968, Bacteriologic localization patterns in bacterial prostatitis and urethritis, Invest Urol, 5, 492
- Neal, 1994, Use of terazosin in prostatodynia and validation of a symptom score questionnaire, Urology, 43, 460, 10.1016/0090-4295(94)90231-3 · doi:10.1016/0090-4295(94)90231-3
- Barbalias, 1998, Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics, J Urol, 159, 883, 10.1016/S0022-5347(01)63761-3 · doi:10.1016/s0022-5347(01)63761-3
- Mehik, 2003, Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome, Urology, 62, 425, 10.1016/S0090-4295(03)00466-7 · DOI · Paper page
- Cheah, 2004, Reliability and validity of the National Institutes of Health–Chronic Prostatitis Symptom Index in a Malaysian population, J Urol, 171, 27, 10.1016/S0022-5347(18)37367-1 · doi:10.1016/s0022-5347(18)37367-1
Cited by
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Metadata
- Authors
- Cheah, P. Y., Liong, M. L., Yuen, K. H., Teh, C. L., Khor, T., Yang, J. R., Yap, H. W., & Krieger, J. N.
- Venue
- Urology
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 64
- Issue
- 5
- Pages
- 881-886
- ISSN
- 0090-4295
- Cited by
- 31
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. https://app.cochat.ai/papers/10.1016/j.urology.2004.06.041
- The paper
- Cheah, P. Y., Liong, M. L., Yuen, K. H., Teh, C. L., Khor, T., Yang, J. R., Yap, H. W., & Krieger, J. N. (2004). Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology. https://doi.org/10.1016/j.urology.2004.06.041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.